Bifogade filer
Kurs & Likviditet
Beskrivning
Land | Sverige |
---|---|
Lista | First North Stockholm |
Sektor | Hälsovård |
Industri | Bioteknik |
2022-08-19 09:01:12
Cline Scientific AB ("Cline" or "The Company") has submitted a patent application related to the StemCART project in China.
This application is a continuation of the patent application filed originally on March 28 2020 which covers the method and product of Cline's cell-based cartilage implant, StemCART. This application is part of the national phase of the patent process where Cline submits national applications in relevant countries around the world.
This patent application aims to protect StemCART as a unique therapy for cartilage damage and is an important part of the product strategy.
For more information, please contact:
Patrik Sundh
Email: patrik.sundh@clinescientific.com
Phone: +46 704 88 79 23